View larger
Hepatitis B Virus e-Antigen Recombinant ( HBeAg )
DescriptionRecombinant e antigen consists of HBV e immunodominant region containing 10 precore residues at its N-terminus and 1-149 residues from the end of precore to its C-terminus. HBV e-Antigen was expressed from E.coli, the purified recombinant
Data sheet
| Storage | HBeAg although stable at 4°C for 1 week, should be stored below -18°C. Please prevent freeze thaw cycles. |
| Formulation | Phosphate buffered saline with 50mM arginine. |
| Purity | Protein is >95% pure as determined by 12% PAGE (coomassie staining). |
| Applications | Immunoassay. |
| Description | Recombinant hepatitis B virus e antigen produced in E.coli, is a 139 a.a (10-149a.a) protein and having a molecular mass of approximately 23kDa. The HBeAg sequence is derived from HBV adw2 and fused to 6xHis Tag at C-terminus. |
| Protein Background | Hepatitis B virus is the main cause for human liver disease, chronic infection frequently causes liver cancer and cirrhosis. The HBV core gene codes 2 distinct protein products, a 21.5-kDa protein being assembled to form nucleocapsid particles designated HBcAg, which wraps the viral DNA as well as the viral polymerase and RNase H, and a precore protein, designated as HBeAg, which is directly to the endoplasmic reticulum, processed at N- and C-terminally and secreted as non-particulate e-anitgen (HBeAg). The pre-core protein contains an extra 29 N-terminal amino acids, serving as a signal peptide to direct the nascent polypeptide into secretory pathway. After the secretion, mature HBeAg is deleted at the residue 149 C-terminally and retains 10 precore residues N-terminally. HBcAg and HBeAg are distinctly recognized by antibodies but highly cross-reactive at the T-cell level.The e antigen is found in the circulation, it is found during the active HBV infection, positive result indicates the risk for contagiousness, and is also used as indicator for the effectiveness of HBV treatment. Positive anti-HBeAg specifies an active stage of acute HBV infection that is in its final stages, the risk for contagiousness is dramatically reduced. |
| Expression host | Escherichia Coli. |
| Amino acid sequence | SKLCLGWLWG MDIDPYKEFG ATVELLSFLP SDFFPSVRDL LDTASALYRE ALESPEHCSP HHTALRQAIL CWGELMTLAT WVGNNLEDPA SRDLVVNYVN TNVGLKIRQL LWFHISCLTF GRETVLEYLV SFGVWIRTPP AYRPPNAPIL STLPETTVVR RRDRGRSPRR RTPSPRRRRS PSPRRRRSQS RESQC. |
| Purification Method | Purified by proprietary chromatographic technique. |